What's happening
This bill requires prescribers to provide an opioid antagonist with a patient's first opioid prescription each year if certain risk factors are present.
Why it matters
Targets patients at elevated risk of overdose. By requiring prescribers to offer an opioid antagonist (like naloxone) when patients have a history of substance use disorder, are prescribed high opioid doses, or are taking opioids with sedatives, the bill aims to directly address scenarios with the highest risk for fatal overdose.
Promotes harm reduction at the point of care. The requirement is triggered at the first opioid prescription of each year (outside of hospitals, nursing homes, or hospice), embedding harm reduction practices into routine healthcare encounters and increasing the likelihood that at-risk patients have immediate access to life-saving medication.
Could normalize co-prescribing of opioid antagonists. By making the process routine for patients with clear risk factors, the bill may reduce stigma around obtaining opioid antagonists and encourage broader acceptance among both providers and patients, potentially leading to more lives saved through increased preparedness for overdose situations.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Prescribe Overdose Antidote With Opioids
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Substituted by A336A
- Advanced to third reading
- 2nd report cal.
- 1st report cal.904
- Print number 2966a
- Amend and recommit to finance
- Reported and committed to finance
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Require Opioid Antagonist Prescription
Signed by Governor · Sponsor Edward Braunstein
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
2966--A
2021-2022 Regular Sessions
IN SENATE
January 26, 2021
Introduced by Sens. HARCKHAM, BROUK -- read twice and ordered printed, and when printed to be committed to the Committee on Health -reported favorably from said committee and committed to the Committee on Finance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the public health law, in relation to prescribing an opioid antagonist with a patient's first opioid prescription in a given year
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 3309 of the public health law is amended by adding a new subdivision 7 to read as follows:
7. With the first prescription to a particular patient of an opioid of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice as defined by section four thousand two of this chapter, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: (a) a history of substance use disorder; (b) high dose or cumulative prescriptions that result in ninety morphine milligram equivalents or higher per day; (c) concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.
§ 2. This act shall take effect on the one hundred eightieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed by the commissioner of health on or before such effective date.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD03417-05-1
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to prescribing an opioid antagonist with a patient's first opioid prescription in a given year
Purpose
To prescribe an opioid antagonist, a drug used to counter the effects of opioid overdose, with a patient's first opioid analgesic prescription each year.
Summary of provisions
Section 1. Adds a new subdivision 7 to Section 3309 of the public health law, which provides that the first opioid prescription to a particular patient each year, in a setting other than a general hospital, nursing home, or hospice care, shall be accompanied with a prescription for an opioid antagonist if any of the following risk factors are present: a history of substance use disorder; high doses or cumulative prescriptions that result in over ninety morphine milligram equivalents or higher per day; concurrent use of opioid and benzodiazepine or nonbenzodiazepine sedative hypnotics.
Read the full memo (670 words)
Section 2. Contains the effective date.
Justification
Drug poisoning is the leading cause of death from injuries in the United States. in New York State and New York City, between 1999 and 2008 the leading cause of accidental death was overdose, ahead of accidental falls and motor vehicle accidents. The vast majority of these overdose deaths occurred inside the home.
According to studies by the Centers for Disease Control and Prevention, drug poisoning deaths involving opioid analgesics, also known as prescription pain relievers, such as codeine and oxycodone, have more than tripled nationally since 1999, and between 2000 and 2011, the rate of drug poisoning deaths involving opioid analgesics in NYC increased by 267%. In 2012, prescription opioid analgesics were involved in 28% of overdose deaths in NYC. Between 2015 and 2016 the opioid overdose death rate in New York State increased by 40%/ Additionally, eighty percent of heroin users have reported that they used opioid analgesics before switching to heroin. As of March 2018, more than 115 people in the United States die every day from overdosing on opioids, according to the CDC.
The CDC has stated that higher doses of opioids are associated with higher risks of overdosing. Furthermore, higher dosages have not been shown to reduce pain over the long term. The CDC maintains the threshold of "higher dosages" begins at 50 morphine milligram equivalents (MME) per day, instructing clinicians to treat the prescription of 50 MME or more as a risk factor for overdose. Dosages of 50 MME at least double the risk of overdose from the risk at less than 20 MME.
Opioid antagonists, such as naloxone, are drugs that reverse the effects of opioids, and are effective in preventing overdose deaths. The avail- ability of an opioid antagonist is crucial in ensuring that overdose deaths do not occur. However, an opioid antagonist can only be effective as an antidote if it is readily accessible when an overdose is happen- ing. Additionally, opioid antagonists are non-habit forming and non-tox- ic. On April 5th, 2018, the United States Surgeon General issued the first national advisory in over a decade, urging all Americans to carry naloxone.
Currently, opioid antagonists can only be used if they are prescribed. A recent NYC Department of Mental Health and Hygiene study supported a co-prescribing mandate to increase the availability of opioid antag- onists. This legislation, by increasing access to opioid antagonists, may be able to save the lives of those at risk for opioid analgesic overdoses.
Legislative history
2019-20: S5150 Passed Senate; same as A5603 (Braunstein) referred to ways and means; 2013-2014: A9365 - Referred to Health 2015-2016: A661 - Referred to Health 2017-2018: Al 531-A - Referred to Health
Fiscal implications
None to the state.
Effective date
This act shall take effect on the one hundred eightieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed by the commissioner of health on or before such effective date.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.